Everything below concerns Cardarine. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-02. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
=== Bioaccumulation and biomagnification === In marine species of the food web Bioaccumulation controls internal concentrations of pollutants, including PFAS, in individual organisms. When bioaccumulation is looked at in the perspective of the entire food web, it is called biomagnification, which is important to track because lower concentrations of pollutants in environmental matrices such as seawater or sediments, can very quickly grow to harmful concentrations in organisms at higher trophic levels, including humans. Notably, concentrations in biota can even be greater than 5000 times those present in water for PFOS and C10–C14 PFCAs. PFAS can enter an organism by ingestion of sediment, through the water, or directly via their diet. It accumulates mainly in areas with high protein content, in the blood and liver, but it is also found to a lesser extent in tissues.
=== 12 April === Russian-installed officials in Zaporizhzhia Oblast claimed that ten people were killed by Ukrainian shelling in Tokmak. One person was killed by Russian shelling in Kharkiv Oblast. Two people were killed in separate Russian attacks in Donetsk Oblast. Russia reported shooting down four drones over an oil refinery in Novoshakhtinsk. One drone fell in the grounds of the oil refinery. Another drone was reportedly shot down over Belgorod Oblast. A former SBU agent who defected to Russia shortly before the 2022 invasion was injured in a car bombing in Moscow. Russia and Ukraine conducted an exchange of war dead, with 99 Ukrainians being exchanged for 23 Russians. The HUR said that Russia had transferred 2,000 personnel from its Pacific Fleet and 400 personnel from the Russian Air Force's 11th Air and Air Defence Forces Army, in addition to halting the deployment of soldiers to Syria on rotation. It claimed that the transfers will either form new units or fill losses in existing units. Norway announced that it would transfer 22 F-16s to Ukraine as well as spare parts, simulators and other equipment to operate them.
== Other interests == Monaghan is an active member of the British Mass Spectrometry Society and has been given life membership for making a significant contribution to the practice of mass spectrometry in the UK. In 2003 the BMSS made John its first President with responsibility to promote the work done by the Society, particularly on the international stage and beyond the core MS community. Monaghan has also been a member and president of the Peterloo Speakers Club in Manchester. He is also a keen cricketer and football referee.
== Side effects == Side effects of doxylamine include dizziness, drowsiness, and dry mouth, among others. Doxylamine is a potent anticholinergic and has a side-effect profile common to such drugs, including blurred vision, dry mouth, constipation, muscle incoordination, urinary retention, mental confusion, and delirium. Because of its relatively long elimination half-life (10–12 hours), doxylamine is associated with next-day effects including sedation, drowsiness, grogginess, dry mouth, and tiredness when used as a hypnotic. This next-day sedation may be described as a "hangover effect". The shorter elimination half-life of diphenhydramine (4–8 hours) compared to doxylamine may give it an advantage over doxylamine as a sleep aid in this regard. Antihistamines like doxylamine are sedating initially but tolerance occurs with repeated use and can result in rebound insomnia upon discontinuation. Occasional case reports of coma and rhabdomyolysis have been reported with doxylamine overdose. This pattern is in contrast to diphenhydramine. Studies of doxylamine's carcinogenicity in mice and rats have produced positive results for both liver and thyroid cancer, especially in the mouse. The carcinogenicity of the drug in humans is not well-studied, and the International Agency for Research on Cancer lists the drug as "not classifiable as to its carcinogenicity to humans". Continuous and/or cumulative use of anticholinergic medications, including first-generation antihistamines, is associated with a higher risk of cognitive decline and dementia in older people.
== Analysis of structure == The internal structure of sea ice can be analyzed using scanning electron microscopy and water-soluble resin. Brine can be drained from the sea ice using centrifugation at sufficiently cold temperatures to prevent melting and to maintain the structural integrity of the sea ice sample. Water-soluble resin is then injected to fill the brine pockets and channels and subsequently polymerized under ultraviolet light at around −12 °C (10 °F). The ice is sublimated by freeze drying, freeing the hardened casts, which can be examined using scanning electron microscopes to determine the structure of the brine pockets and channels and the volume of habitable space available to microbes.
Sources: en.wikipedia.org
== Further reading == Morrison, G. C.; Nazaroff, W. W. (2002). "Ozone interactions with carpet: secondary emissions of aldehydes". Environmental Science & Technology. 36 (10): 2185–92. Bibcode:2002EnST...36.2185M. doi:10.1021/es0113089. PMID 12038828.
The glass bulb of a general service lamp can reach temperatures between 200 and 260 °C (392 and 500 °F). Lamps intended for high power operation or used for heating purposes will have envelopes made of hard glass or fused quartz. If a light bulb envelope leaks, the hot tungsten filament reacts with air, yielding an aerosol of brown tungsten nitride, brown tungsten dioxide, violet-blue tungsten pentoxide, and yellow tungsten trioxide that then gets deposited on the nearby surfaces or the bulb interior.
== History == The German chemist Adolph Strecker discovered the series of chemical reactions that produce an amino acid from an aldehyde or ketone. Using ammonia or ammonium salts in this reaction gives unsubstituted amino acids. In the original Strecker reaction acetaldehyde, ammonia, and hydrogen cyanide combined to form after hydrolysis alanine. Using primary and secondary amines in place of ammonium was shown to yield N-substituted amino acids. The classical Strecker synthesis gives racemic mixtures of α-amino acids as products, but several alternative procedures using asymmetric auxiliaries or asymmetric catalysts have been developed. The asymmetric Strecker reaction was reported by Harada in 1963. The first reported asymmetric synthesis via a chiral catalyst was published in 1996. However, this was retracted in 2023.
, in the half-plane. The circle shown in the figure indicates a surface on which the maximum shear stress is constant. From this stress field, the strain components and thus the displacements of all material points may be determined.
== Discovery == The discovery of thymosins in the mid 1960s emerged from investigations of the role of the thymus in development of the vertebrate immune system. Begun by Allan L. Goldstein in the Laboratory of Abraham White at the Albert Einstein College of Medicine in New York, the work continued at University of Texas Medical Branch in Galveston and at The George Washington University School of Medicine and Health Sciences in Washington D.C. The supposition that the role of the thymus might involve a hormone-like mechanism led to the isolation from thymus tissue of a biologically active preparation. Known as "Thymosin Fraction 5", this was able to restore some aspects of immune function in animals lacking thymus gland. Fraction 5 was found to contain over 40 small peptides (molecular weights ranging from 1000 to 15,000 Da.), which were named "thymosins" and classified as α, β and γ thymosins on the basis of their behaviour in an electric field. Although found together in Fraction 5, they are now known to be structurally and genetically unrelated. Thymosin β1 was found to be ubiquitin (truncated by two C-terminal glycine residues). When individual thymosins were isolated from Fraction 5 and characterized, they were found to have extremely varied and important biological properties. However they are not truly thymic hormones in that they are not restricted in occurrence to thymus and several are widely distributed throughout many different tissues.
Sources: en.wikipedia.org
Stimulants, also known as "psychostimulants", induce euphoria with improvements in mental and physical function, such as enhanced alertness, wakefulness, and locomotion. Stimulants are also occasionally called "uppers". Depressants or "downers", which decrease mental or physical function, are in stark contrast to stimulants and are considered to be their functional opposites. Stimulants enhance the activity of the central and peripheral nervous systems. Common effects may include increased alertness, awareness, wakefulness, endurance, productivity, and motivation, arousal, locomotion, heart rate, and blood pressure, and a diminished desire for food and sleep. Use of stimulants may cause the body to significantly reduce its production of endogenous compounds that fulfill similar functions. Once the effect of the ingested stimulant has worn off the user may feel depressed, lethargic, confused, and dysphoric. This is colloquially termed a "crash" and may promote reuse of the stimulant. Amphetamines are a significant cause of drug-induced psychosis. Importantly, a 2019 meta-analysis found that 22% of people with amphetamine-induced psychosis transition to a later diagnosis of schizophrenia. Examples of stimulants include:
== Biography == Vincent du Vigneaud was born in Chicago in 1901. Of French descent, he was the son of inventor and mechanic Alfred du Vigneaud and Mary Theresa. He studied at the Schurz High School and completed secondary education in 1918. His interest in sulfur began when he entered high school and his new friends invited him to run chemical experiments on explosives using sulfur. During World War I, senior students were made to work on farms, and du Vigneaud worked near Caledonia, Illinois. There he became an expert in milking cows, which inspired him to become a farmer. However, his elder sister, Beatrice, persuaded him to take up chemistry at the University of Illinois at Urbana-Champaign, after which he enrolled in the chemical engineering course. He later recalled: I found during the first year that it was chemistry rather than engineering that appealed to me most. I switched to a major in chemistry, since I was deeply impressed by the senior student's work, especially in organic chemistry. I also found that I was most interested in those aspects of organic chemistry that had to do with medical substances and began to develop an interest in biochemistry.His interest was aroused by lectures of Carl Shipp Marvel and Howard B. Lewis, whom he remembered as being 'extremely enthusiastic about sulfur." With little support from the family, he found odd jobs to support himself. After receiving his MS in 1924 he joined DuPont. He married Zella Zon Ford, whom he met on June 12, 1924, while working as a waiter during his university course.
Indeed, at least four people have died in the course of either preparation for or institution of bone marrow transplantation for EB, out of only a small group of patients treated so far. The mechanism of action of this therapy is unclear as hematopoietic stem cells are not thought to contribute to epithelial lineages. Rather, it is speculated that cross-correction from tissue-resident graft-derived immune cells contributes to the observed clinical benefit. A pilot study performed in 2015 suggests that systemic granulocyte-colony stimulating factor (G-CSF) may promote increased wound healing in people with dystrophic EB. Transplanting skin derived from genetically modified stem cells onto the wound surfaces has been studied with a report of improvements in one person. A 2017 clinical trial with male RDEB (recessive dystrophic EB) patients conducted successful grafting of type VII gene corrected keratinocytes (COL7A1 gene correction using retrovirus transduction), without any serious adverse effects. Type VII collage formation was observed at the dermis-epidermis junction in significant amounts. A 2020 study demonstrated the safe allogenic grafting of acellular dermal matrix/scaffolds in EB patients without any observed infection or necrosis and instead noted fewer required dressing changes, promoted wound healing, pain reduction, and an overall improvement in the quality of life of the patients. In 2022, a pharmaceutical gel made out of birch bark extract from Betula pendula and Betula pubescens was approved by the European Union as a treatment for epidermolysis bullosa.
==== Retinoids ==== Retinoids, a class of natural and synthetic vitamin A analogues, are widely utilized for their anti-aging effects, specifically in the reduction of facial wrinkles and fine lines. Tretinoin (Retin-A) and tazarotene (Tazorac) are the only topical retinoids approved as medical agents for the treatment of wrinkles and fine lines from photodamage. Other retinoids, such as retinol, retinaldehyde, and retinyl palmitate, are commonly found in over-the-counter cosmeceuticals and have some evidence for reducing wrinkles and fine lines but are regulated as cosmetics rather than medicines. Retinoids function by binding to retinoic acid receptors (RAR) and retinoid-X receptors (RXR), which promotes keratinocyte proliferation, increases epithelial cell turnover, stimulates collagen synthesis, and inhibits collagen degradation. Retinoids also appear to improve the epidermal barrier and reduce transepithelial water loss.
== Additional facts == On Malacards, it has an information score of 7/100. There are currently no known genes or related disorders related to chondronectins. There are no current therapeutics, variations, expressions, pathways, GO terms or genetic tests for chondronectins currently. Chondronectin has been described as a trimeric glycoprotein with compact globular properties. The protein has most commonly been detected in cartilage related fluids such as synovial fluid and plasma. Chondronectin functions primarily as an attachment factor between chondrocytes and collagen based matrix materials. Most currently available information on chondronectin comes from isolation and characterization studies completed during the 1980s.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.